跳至主要内容
临床试验/NCT03172351
NCT03172351已完成不适用

Prospective Randomized Clinical Trial Comparing Extended Depth of Focus Intraocular Lenses With a Monofocal Intraocular Lens

Carl Zeiss Meditec AG2 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2017年5月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
216
试验地点
2
主要终点
Defocus curve measurement

研究概览

简要总结

prospective, comparative (3 arms), randomized, multicentric clinical trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient informed of the consequences and constraints of the Clinical Investigational Plan and who has given his/her written informed consent;
  • Patients of any gender, aged 50 to 80 years;
  • Assured follow-up examinations;
  • clinically significant bilateral cataract;

排除标准

  • Patients unable to meet the limitations of the Clinical Investigational Plan or likely of non-cooperation during the trial;
  • Patients whose freedom is impaired by administrative or legal order;
  • Current participation in another drug or device investigation;
  • Ocular disorders, other than cataract, that could potentially cause future acuity loss to a level of 0.20 logMAR (corrected) or worse in either eye
  • Any anterior segment pathology that could significantly affect outcomes (e.g. chronic uveitis, iritis, corneal dystrophy, etc.)
  • Pseudoexfoliations syndrome
  • Pathologic miosis or Pharmacotherapy with miotic agent
  • Keratoconus
  • Chronic or recurrent uveitis
  • Diabetic retinopathy
  • Uncontrolled glaucoma and or IOP>24mmHg
  • Choroidal hemorrhage,
  • All kind of infections (acute ocular disease, external/internal infection, systemic infection)
  • Traumatic cataract
  • Microphthalmia
  • Amblyopia
  • Degenerative visual disorders (e.g. macular degeneration, optic nerve atrophy, or retinal disorders)
  • Patient expected to require retinal laser treatment before the end of the 4-6 months follow-up
  • Previous intraocular and corneal surgery
  • Expected postop. astigmatism greater than 1 D
  • Any type of corneal disorder
  • Systemic or ocular pharmacotherapy, which can impact the visual acuity,
  • Former, current or foreseeable application of Tamsulosin or Silodosin (e.g. Flomax, Flomaxtra, Rapflo) ) which potentially can cause the floppy iris syndrome, insufficient dilation, or missing of appropriate iris structures which can compromise the standard procedure according to the investigator's opinion
  • Patients who are unable to fixate for longer time (e.g. strabismus, nystagmus)
  • pregnancy or lactation period for female patients

结局指标

主要结局

Defocus curve measurement

时间窗: 1 month

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

EDoF IOLs vs Monofocal IOL | 临床试验